Mangalam Organics Limited reported a sharp divergence between top-line growth and bottom-line profitability for the quarter ended June 30, 2026 (Q1FY27). Consolidated net profit after tax (PAT) declined 41% year-on-year to ₹7.27 crore from ₹12.23 crore in Q1FY26, even as revenue from operations surged 22% to ₹179.09 crore. The Board of Directors approved the unaudited financial results on July 28, 2026, following review by the Audit Committee. Statutory auditors expressed an unmodified review opinion on the financial statements.

Standalone figures also reflected profit compression, with net profit falling 23% YoY to ₹5.32 crore from ₹6.92 crore. Standalone total income rose 37% to ₹163.14 crore. The company submitted its investor presentation for the quarter and the full financial year ended March 31, 2026, to the stock exchanges on July 30, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

*Note: Pre-tax profit figures used as proxy for EBITDA in standalone context where explicit EBITDA was not separately itemized in the summary table but derived from PBT adjustments in detailed statements.

The paid-up equity share capital remained unchanged at ₹8.56 crore. Consolidated earnings per share stood at ₹8.49, down from ₹14.28 in the previous year’s quarter.

What the Numbers Show

The primary driver of the profit decline is margin compression rather than operational volume issues. While consolidated revenue grew by 22%, consolidated EBITDA increased by only 3% to ₹22.21 crore, causing the EBITDA margin to contract from 14.74% in Q1FY26 to 12.40% in Q1FY27. This indicates that rising input costs or other operating expenses were not fully passed on to customers or offset by efficiency gains.

In the standalone segment, the disconnect is more severe: revenue surged 37%, yet pre-tax profit fell 23%. This suggests significant headwinds in the core manufacturing operations, potentially linked to higher cost of materials consumed or specific one-off charges not present in the prior year. The consolidated balance sheet as of March 2026 showed total assets of ₹740 crore against total liabilities of ₹740 crore, with borrowings increasing from ₹35 crore in March 2025 to ₹55 crore in non-current liabilities and ₹301 crore in current liabilities, indicating increased leverage to fund operations or expansion.

Mangalam Organics Limited reported a 22.6% year-on-year decline in standalone net profit to ₹6.38 lakh for the quarter ended June 30, 2026, driven by a sharper rise in material costs than revenue growth. While revenue from operations surged 43.5% YoY to ₹163.09 crore, cost of materials consumed jumped 58.2% to ₹117.94 crore, compressing margins. The Board of Directors approved the unaudited standalone and consolidated financial results on July 28, 2026, following review by the Audit Committee.

The Board also fixed the date for the 44th Annual General Meeting (AGM) on September 24, 2026, to be held via Video Conferencing/Other Audio-Visual Means (VC/OAVM). Shareholders holding shares as of the cut-off date, September 16, 2026, are eligible to vote. Remote e-voting will be available from September 21, 2026, to September 23, 2026, through MUFG Intime India Pvt. Ltd. The register of members will remain closed from September 17, 2026, to September 24, 2026.

Financial Performance Highlights

Standalone revenue from operations rose to ₹163.09 crore from ₹113.63 crore in the corresponding quarter of the previous year. However, profit before tax fell to ₹6.38 lakh from ₹8.24 lakh. Consolidated net profit contracted more sharply by 40.5% to ₹8.70 lakh, compared to ₹14.69 lakh in Q1FY26. Finance costs decreased slightly by 6.5% to ₹58.73 lakh standalone, providing some offset to the rising operational expenses.

Note: Figures in Crores (Cr) and Lakhs (Lakh) as per source document. EPS in Rupees.

Auditor Appointment and Governance

The Board approved the appointment of M/s JMT & Associates, Chartered Accountants (Firm Registration No. 104167W), as Statutory Auditors for a five-year term commencing from the conclusion of the 44th AGM until the 49th AGM. This replaces M/s NGST & Associates, whose second term concludes with the current AGM. The appointment is subject to shareholder approval at the AGM. M/s JMT & Associates is a Peer Reviewed Firm holding Peer Review Certificate No. 016481.

The Draft Board’s Report for the financial year ended March 31, 2026, was also approved at the meeting. The statutory auditors, M/s NGST & Associates, have issued an unmodified review opinion on the interim financial results, confirming compliance with Ind-AS 34 and SEBI Listing Regulations.

What the Numbers Show

A notable divergence exists between standalone and consolidated performance. While standalone revenue grew 43.5%, consolidated revenue grew only 22.2%. Similarly, consolidated profit declined by over 40%, significantly worse than the 22.6% drop in standalone profit. This suggests that subsidiaries—Mangalam Brands Private Limited, Mangalam Pooja Stores Private Limited, and Mangalam Speciality Chemicals Private Limited—may be facing higher cost pressures or lower margin profiles compared to the parent entity. Investors should monitor segment-wise contributions in future filings to assess if this trend persists.